Blog - QualityStocks

FridayOct 30, 2026 3:54 pm

QualityStocksNewsBreaks – Market Street Capital Inc. Brings Capital Markets Expertise to Healthcare Financing

Market Street was featured in an article that highlights its capital markets and financial advisory services for middle-market healthcare companies navigating reimbursement uncertainty, industry consolidation, heightened compliance scrutiny and increasingly selective investors. With potential Medicare laboratory reimbursement cuts beginning in 2027, lenders and private equity sponsors are placing greater emphasis on revenue diversification, payer relationships, regulatory compliance and sustainable cash flow when evaluating financing and acquisition opportunities. Market Street supports healthcare businesses through debt financing, private equity raises, mergers and acquisitions, valuation and strategic advisory services, connecting clients with banks, private credit funds, institutional investors and other potential capital sources.…

FridayOct 30, 2026 3:34 pm

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Strengthens Portfolio with Emergent Metals Acquisition

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) was featured in a recent article that discussed expansion of its Nevada gold and silver portfolio through a definitive agreement to acquire Emergent Metals Corp., which would consolidate its ownership of the West Santa Fe property, eliminate royalty obligations on West Santa Fe and 27 adjacent York claims, and add the strategically located New York Canyon project. The transaction would increase Lahontan’s Walker Lane land package to more than 93 square kilometers as gold prices remain historically elevated,…

FridayOct 30, 2026 2:40 pm

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Builds Broader Public Safety Platform Around Integrated Solutions

Wrap Technologies (NASDAQ: WRAP) is expanding its public safety technology strategy by connecting remote restraint, scenario-based training, evidence management and emerging threat-detection systems into a more integrated offering. Its portfolio includes the BolaWrap 150 restraint device, WRAP Reality virtual reality training simulator and WrapShield platform, which initially focuses on detecting and responding to unmanned aircraft threats. The company recently appointed veteran law enforcement instructor John “Chappy” Chapman as vice president of Training and Missions to oversee a planned four-level instructor credentialing framework, digital learning expansion and broader adoption of its Non-Lethal Response doctrine. WRAP is also developing Wraptor MX, a…

FridayOct 30, 2026 1:31 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Expands NAMs Strategy to Advance BiTAC(R) Therapies

VERAXA Biotech (NASDAQ: VRXA) is expanding its use of human-relevant preclinical testing methods across its antibody-based cancer drug development programs, aiming to improve the clinical relevance of research findings while reducing animal testing. The company is implementing New Approach Methodologies (“NAMs”), including three-dimensional tumor spheroid models and patient-derived tumor models, in support of its BiTAC(R) T-cell engagers, antibody-drug conjugates and bispecific antibody-drug conjugates. VERAXA reported that its lead BiTAC T-cell engager demonstrated selective, potent T-cell-mediated tumor-cell killing across 10 patient-derived non-small cell lung cancer models, while relevant controls showed minimal activity. The ex vivo study required approximately 10 mice, compared…

FridayOct 30, 2026 12:54 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Taps Thermo Fisher’s Clinical Research Business for Lucid-MS Trial

Quantum BioPharma (NASDAQ: QNTM) has signed a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research business to support the Phase 2 clinical trial of Lucid-MS, its investigational drug candidate for progressive multiple sclerosis (“MS”). Following U.S. Food and Drug Administration clearance of its Investigational New Drug application in August 2026, the agreement moves the program toward clinical implementation with a contract research organization experienced in central nervous system and MS studies. Unlike many existing MS treatments that primarily target the immune system, Lucid-MS is designed to protect myelin, the protective coating around nerve fibers, by inhibiting PAD2, an enzyme…

FridayOct 30, 2026 11:18 am

QualityStocksNewsBreaks – Hydrofarm Holdings Group, Inc. (NASDAQ: HYFM) Closes $8.3 Million Offering, Eliminates Senior Secured Term Loan

Hydrofarm (NASDAQ: HYFM) announced the closing of its previously disclosed registered direct offering of 1,599,400 common shares at $0.905 per share and concurrent private placement of 7,611,575 unregistered common shares or pre-funded warrants and 9,210,975 common stock purchase warrants. The transactions generated approximately $8.3 million in gross proceeds before fees and expenses. Chairman and CEO Bill Toler, along with other company officers, directors and their affiliates, participated on the same terms as other investors. Hydrofarm intends to use the net proceeds for general corporate purposes. ThinkEquity served as sole placement agent and advisor. Concurrent with the closing, Hydrofarm entered into…

FridayOct 30, 2026 10:30 am

SuperQ Quantum Computing Inc. Bridges Quantum Software and Hardware with Interoperability Strategy

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements. SuperQ's live Super(TM) platform enables users to address complex computational challenges, while the company continues developing its broader hybrid quantum computing ecosystem. Super OS(TM) is in development as a cloud and on-site operating system for hybrid quantum computing, while Super Nova(TM) represents SuperQ's quantum computer and foundry initiative. The company's strategy brings together existing software capabilities, operating system development, hardware innovation and defense applications. As quantum computing moves toward practical applications, a key challenge is connecting emerging quantum technologies with the computing infrastructure organizations already use. Beyond…

FridayOct 30, 2026 10:23 am

QualityStocksNewsBreaks – Adaptogenics Health Corp. (CSE: ADPT) Gains Industry Relevance as FDA Eases Restrictions on Pharmacy-Compounded Peptides, NBC News Reports

This article has been disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) is drawing attention amid changes to the regulatory environment for peptide-based treatments, as federal health officials move to allow compounding pharmacies to immediately offer six previously restricted peptides without waiting for formal rulemaking. According to an Oct. 28 NBC News report by Berkeley Lovelace Jr., the Department of Health and Human Services is exercising "enforcement discretion," temporarily suspending legal action against qualifying pharmacies that compound BPC-157, epitalon, KPV, MOTS-c, semax and TB-500. The Food and Drug Administration ("FDA") is requiring pharmacies…

FridayOct 30, 2026 10:19 am

QualityStocksNewsBreaks – Adaptogenics Health Corp. (CSE: ADPT) Sees Regulatory Landscape Shift as Federal Policy Permits Compounding of Six Peptides, Reuters Reports

This article has been disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) operates in a peptide sector undergoing a significant regulatory shift following the publication of a new federal policy permitting licensed pharmacies and physicians to compound six previously restricted peptides under specified conditions. According to an Oct. 28 Reuters report by Sneha S K, with additional reporting by Kamal Choudhury and Siddhi Mahatole, the policy, published in the Federal Register, allows compounding of BPC-157, TB-500, epitalon, KPV, MOTS-c and Semax without Food and Drug Administration ("FDA") enforcement action, provided compounders meet requirements…

FridayOct 30, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) Demonstrates Long-Distance Robotic Cardiac Surgery at Industry Events

The company demonstrated its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console at two international medical conferences in October 2026. At the European Association for Cardio-Thoracic Surgery annual meeting in Barcelona, CEO Dr. Sudhir Srivastava performed a robotic-assisted atrial septal defect procedure on a patient approximately 7,500 miles away in Bengaluru, India. Four additional robotic telesurgeries were performed or broadcast during the inaugural Society of Robotic Surgery India conference, covering urological, colorectal, pediatric and gynecological procedures. The company reported 205 telesurgeries performed with the SSi Mantra system as of October 23, 2026, including cardiac procedures. The demonstrations highlight…

Site Search

Company Search